Northern Trust’s Applied Therapeutics APLT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-245,144
| Closed | -$24.5K | – | 4403 |
|
|
2025
Q4 | $24.5K | Buy |
245,144
+71,429
| +41% | +$45.4K | ﹤0.01% | 4373 |
|
|
2025
Q3 | $105K | Sell |
173,715
-1,540
| -0.9% | -$725 | ﹤0.01% | 4125 |
|
|
2025
Q2 | $54.5K | Sell |
175,255
-592,949
| -77% | -$229K | ﹤0.01% | 4217 |
|
|
2025
Q1 | $376K | Sell |
768,204
-6,113
| -0.8% | -$3.6K | ﹤0.01% | 3686 |
|
|
2024
Q4 | $663K | Buy |
774,317
+13,257
| +2% | +$83.1K | ﹤0.01% | 3555 |
|
|
2024
Q3 | $6.47M | Buy |
761,060
+527,276
| +226% | +$3.11M | ﹤0.01% | 2328 |
|
|
2024
Q2 | $1.09M | Buy |
233,784
+127,331
| +120% | +$603K | ﹤0.01% | 3206 |
|
|
2024
Q1 | $724K | Sell |
106,453
-144
| -0.1% | -$646 | ﹤0.01% | 3432 |
|
|
2023
Q4 | $357K | Buy |
106,597
+7,650
| +8% | +$19K | ﹤0.01% | 3666 |
|
|
2023
Q3 | $246K | Sell |
98,947
-10,274
| -9% | -$16.9K | ﹤0.01% | 3730 |
|
|
2023
Q2 | $140K | Buy |
109,221
+58,261
| +114% | +$77.3K | ﹤0.01% | 3949 |
|
|
2023
Q1 | $41.3K | Hold |
50,960
| – | – | ﹤0.01% | 4297 |
|
|
2022
Q4 | $38.7K | Hold |
50,960
| – | – | ﹤0.01% | 4345 |
|
|
2022
Q3 | $47K | Buy |
50,960
+15,369
| +43% | +$18.4K | ﹤0.01% | 4338 |
|
|
2022
Q2 | $34K | Sell |
35,591
-128,792
| -78% | -$211K | ﹤0.01% | 4520 |
|
|
2022
Q1 | $347K | Sell |
164,383
-13,298
| -7% | -$35.6K | ﹤0.01% | 3880 |
|
|
2021
Q4 | $1.59M | Sell |
177,681
-519
| -0.3% | -$6.82K | ﹤0.01% | 3336 |
|
|
2021
Q3 | $2.96M | Sell |
178,200
-11,804
| -6% | -$204K | ﹤0.01% | 3060 |
|
|
2021
Q2 | $3.95M | Buy |
190,004
+11,035
| +6% | +$209K | ﹤0.01% | 2980 |
|
|
2021
Q1 | $3.36M | Buy |
178,969
+10,421
| +6% | +$225K | ﹤0.01% | 2987 |
|
|
2020
Q4 | $3.71M | Sell |
168,548
-3,862
| -2% | -$80.4K | ﹤0.01% | 2849 |
|
|
2020
Q3 | $3.58M | Buy |
172,410
+62,853
| +57% | +$1.63M | ﹤0.01% | 2743 |
|
|
2020
Q2 | $3.96M | Buy |
109,557
+7,111
| +7% | +$298K | ﹤0.01% | 2656 |
|
|
2020
Q1 | $3.35M | Buy |
102,446
+42,790
| +72% | +$1.73M | ﹤0.01% | 2543 |
|
|
2019
Q4 | $1.63M | Buy |
59,656
+36,438
| +157% | +$624K | ﹤0.01% | 3231 |
|
|
2019
Q3 | $256K | Buy |
23,218
+16,076
| +225% | +$152K | ﹤0.01% | 3698 |
|
|
2019
Q2 | $59K | Buy |
+7,142
| New | +$67.6K | ﹤0.01% | 4059 |
|
Northern Trust's APLT Position: Q1 2026 in Review
Northern Trust sold out of Applied Therapeutics (APLT) in Q1 2026, closing a stake of 245,144 shares — an estimated $24.5K sold.
Northern Trust first reported a position in APLT in Q2 2019 and held it in 27 quarters. The position peaked at $6.47M in Q3 2024. 0 funds tracked by Wall St. Rank hold APLT as of Q1 2026.
- Northern Trust reported no remaining Applied Therapeutics position as of Q1 2026 after selling out during the quarter.
- Northern Trust sold 245,144 Applied Therapeutics shares in Q1 2026, an estimated $24.5K.
- Northern Trust first reported a position in Applied Therapeutics in Q2 2019 and held it in 27 quarters.
- Northern Trust's Applied Therapeutics position peaked at $6.47M in Q3 2024.
- 0 funds tracked by Wall St. Rank held Applied Therapeutics as of Q1 2026.
Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.